149 related articles for article (PubMed ID: 21355316)
21. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
[TBL] [Abstract][Full Text] [Related]
22. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
[TBL] [Abstract][Full Text] [Related]
23. Doxorubicin eluting beads - 1: effects of drug loading on bead characteristics and drug distribution.
Lewis AL; Gonzalez MV; Leppard SW; Brown JE; Stratford PW; Phillips GJ; Lloyd AW
J Mater Sci Mater Med; 2007 Sep; 18(9):1691-9. PubMed ID: 17483878
[TBL] [Abstract][Full Text] [Related]
24. Drug-loaded microspheres for the treatment of liver cancer: review of current results.
Kettenbach J; Stadler A; Katzler IV; Schernthaner R; Blum M; Lammer J; Rand T
Cardiovasc Intervent Radiol; 2008; 31(3):468-76. PubMed ID: 18228095
[TBL] [Abstract][Full Text] [Related]
25. [Comparison of doxorubicin-eluting bead transarterial chemoembolization (DEB-TACE) with conventional transarterial chemoembolization (TACE) for the treatment of hepatocellular carcinoma].
Ferrer Puchol MD; la Parra C; Esteban E; Vaño M; Forment M; Vera A; Cosín O
Radiologia; 2011; 53(3):246-53. PubMed ID: 21295802
[TBL] [Abstract][Full Text] [Related]
26. [Studies on pharmacologic disposition of adriamycin in dog after hepatic arterial embolization with adriamycin carboxymethyl-dextran-microspheres].
He SM; Sun YC; Wei SL; Wu CB; Wang PU; Wang SD; Xie JX
Yao Xue Xue Bao; 1993; 28(11):859-64. PubMed ID: 7516606
[TBL] [Abstract][Full Text] [Related]
27. Preparation and drug controlled release of porous octyl-dextran microspheres.
Hou X; Liu Y
J Biomater Sci Polym Ed; 2015; 26(15):1051-66. PubMed ID: 26230155
[TBL] [Abstract][Full Text] [Related]
28. In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.
Hiwale P; Lampis S; Conti G; Caddeo C; Murgia S; Fadda AM; Monduzzi M
Biomacromolecules; 2011 Sep; 12(9):3186-93. PubMed ID: 21809827
[TBL] [Abstract][Full Text] [Related]
29. Crosslinked gelatin matrices: release of a random coil macromolecular solute.
Mwangi JW; Ofner CM
Int J Pharm; 2004 Jul; 278(2):319-27. PubMed ID: 15196637
[TBL] [Abstract][Full Text] [Related]
30. Transcatheter chemo-embolization for hepatocellular carcinoma and certain hepatic metastasis.
Haq TU
J Pak Med Assoc; 2004 Mar; 54(3):142-5. PubMed ID: 15129875
[No Abstract] [Full Text] [Related]
31. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
[TBL] [Abstract][Full Text] [Related]
32. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study.
Caturelli E; Siena DA; Fusilli S; Villani MR; Schiavone G; Nardella M; Balzano S; Florio F
Radiology; 2000 Apr; 215(1):123-8. PubMed ID: 10751477
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacokinetics of doxorubicin alginate microspheres and evaluation of its hepatic arterial embolization in vivo].
Liu D; Wang PC; Qi XR; Zou Q; Zou YH; Hong H
Yao Xue Xue Bao; 2006 Aug; 41(8):778-83. PubMed ID: 17039787
[TBL] [Abstract][Full Text] [Related]
34. [Liver tumor targeting of drugs: Spherex, a vascular occlusive agent].
Taguchi T
Gan To Kagaku Ryoho; 1995 Jun; 22(7):969-76. PubMed ID: 7794007
[TBL] [Abstract][Full Text] [Related]
35. Safety of Curcuma aromatica oil gelatin microspheres administered via hepatic artery.
Deng SG; Wu ZF; Li WY; Yang ZG; Chang G; Meng FZ; Mo LL
World J Gastroenterol; 2004 Sep; 10(18):2637-42. PubMed ID: 15309710
[TBL] [Abstract][Full Text] [Related]
36. Trans-arterial p53-gene-embolization with gelatin sponge microparticles for hepatocellular carcinoma with BCLC stage B: single-center experience.
Liu Y; Zhang Y; Bautista D; Tang S; Zhou J; Li C; Zhao G
Cell Biochem Biophys; 2015 Jan; 71(1):99-104. PubMed ID: 25323562
[TBL] [Abstract][Full Text] [Related]
37. Gelatin microspheres: correlation between embolic effect/degradability and cross-linkage/particle size.
Ohta S; Nitta N; Watanabe S; Tomozawa Y; Sonoda A; Otani H; Tsuchiya K; Nitta-Seko A; Yamamoto A; Takahashi M; Murata K
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1105-11. PubMed ID: 23238849
[TBL] [Abstract][Full Text] [Related]
38. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients.
Malagari K; Chatzimichael K; Alexopoulou E; Kelekis A; Hall B; Dourakis S; Delis S; Gouliamos A; Kelekis D
Cardiovasc Intervent Radiol; 2008; 31(2):269-80. PubMed ID: 17999110
[TBL] [Abstract][Full Text] [Related]
39. [Segmental simultaneous arterio-portal chemoembolization of hepatocellular carcinoma].
Oi H
Nihon Rinsho; 1991 Aug; 49(8):1910-5. PubMed ID: 1664898
[No Abstract] [Full Text] [Related]
40. [Effects of hyperthermia combined with chemoembolization using degradable starch microspheres in the treatment of hepatocellular carcinoma].
Itani K; Yoshikawa T; Tainaka K; Oyamada Y; Sugino S; Kondo M; Seto O
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1418-22. PubMed ID: 2837995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
